| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10101311 | The American Journal of Surgery | 2005 | 8 Pages |
Abstract
It is cautiously optimistic that these therapies can be used as a routine adjunct in the treatment of selected breast cancers. The challenge will lie in the ability to identify multifocal disease and in situ carcinoma as well as to ensure complete and effective eradication of the breast cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Tara L. M.D., Rache M. (F.A.C.S.),